IPAH Stock Overview
Interpharm Holdings, Inc. develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Interpharm Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.01 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 0% |
| 3 Year Change | -99.80% |
| 5 Year Change | 0% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| IPAH | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -1.5% | -3.2% |
| 1Y | 0% | 9.7% | 19.3% |
Return vs Industry: IPAH underperformed the US Pharmaceuticals industry which returned 9.7% over the past year.
Return vs Market: IPAH underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| IPAH volatility | |
|---|---|
| IPAH Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IPAH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IPAH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | n/a | n/a | n/a |
Interpharm Holdings, Inc. develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals. The company supplies its medicines to major retailers, wholesalers, managed care organizations, and national distributors. The company was founded in 1984 and is based in Hauppauge, New York.
Interpharm Holdings, Inc. Fundamentals Summary
| IPAH fundamental statistics | |
|---|---|
| Market cap | US$66.00 |
| Earnings (TTM) | -US$33.69m |
| Revenue (TTM) | US$69.21m |
0.0x
P/S Ratio0.0x
P/E RatioIs IPAH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IPAH income statement (TTM) | |
|---|---|
| Revenue | US$69.21m |
| Cost of Revenue | US$57.21m |
| Gross Profit | US$12.00m |
| Other Expenses | US$45.69m |
| Earnings | -US$33.69m |
Last Reported Earnings
Dec 31, 2007
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did IPAH perform over the long term?
See historical performance and comparison